Living Beyond Breast Cancer

U.S. FDA Approves FoundationOne®CDx as a Companion Diagnostic for AstraZeneca’s Truqap™ (capivasertib) in combination with Faslodex® (fulvestrant) to Identify Patients with HR-Positive, HER2-Negative Advanced Breast Cancer

Retrieved on: 
Monday, November 20, 2023
Research, FDA, Clinical Trials, Biotechnology, General Health, Pharmaceutical, Health, Science, Oncology, Other Science, Breast, Foundation Medicine, Food, Prevalence, Progression-free survival, Fulvestrant, Disease, Breast cancer, Living Beyond Breast Cancer, Patient, Neoplasm, HER2, Cancer, NGS, Recurrence, Pharmaceutical industry, Medical imaging, Vaccine

“This companion diagnostic approval adds to the growing utility of Foundation Medicine’s high-quality diagnostic test portfolio in treating advanced breast cancer.”

Key Points: 
  • “This companion diagnostic approval adds to the growing utility of Foundation Medicine’s high-quality diagnostic test portfolio in treating advanced breast cancer.”
    Foundation Medicine is the only company with an FDA-approved portfolio of tissue and blood-based comprehensive genomic profiling tests.
  • Using a tissue sample, the FDA-approved FoundationOne CDx test analyzes more than 300 cancer-related genes for genomic alterations in a patient’s tumor.
  • The test currently has over 35 companion diagnostic indications, five of which are in breast cancer.
  • The company has 60% of all U.S. companion diagnostic approvals for next generation sequencing (NGS) testing.

Allergan Aesthetics Supports Breast Cancer Patients and Celebrates Breast Reconstruction Patients Through The Reblossom Project

Retrieved on: 
Thursday, October 19, 2023
Reconstructive surgery, Patient, Partnership, Living Beyond Breast Cancer, Education, Survivor, NYSE, Breast implant, Nursing, NXT TakeOver: R Evolution, Breast, Physician, Fatigue, Coffee, Rupture, B-cell lymphoma, Organization, Arthralgia, Research, Young Survival Coalition, Trauma, New York Fashion Week, Senior, Sister, Immune system, LBBC, Confusion, Breast cancer, Adelphi, Ukraine Air Alliance Flight 4050, Myalgia, Woman, AbbVie, Amazon, Collection, Mastectomy, Cancer, Diagnosis, Beauty, Medical imaging, Birth control

IRVINE, Calif., Oct. 19, 2023 /PRNewswire/ -- Yesterday, on Breast Reconstruction Awareness Day (National BRA Day), Allergan Aesthetics, an AbbVie company (NYSE: ABBV), launched Reblossom, a coffee table book featuring a collection of patient stories and photographs that celebrates the resilience of breast cancer survivors and thrivers. The Reblossom book was created through the support of Allergan Aesthetics by photographer Erez Sabag in collaboration with Board-Certified Plastic Surgeon, Dr. Jonathan Bank. Reblossom explores the stories of 12 women and their unique journeys with breast cancer and breast reconstruction. All proceeds from the purchase of the Reblossom book benefit Living Beyond Breast Cancer (LBBC), a national nonprofit organization that connects people with trusted information and a community of support. To donate and receive your copy of the Reblossom book, visit www.reblossomexhibit.com.

Key Points: 
  • Reblossom explores the stories of 12 women and their unique journeys with breast cancer and breast reconstruction.
  • In addition to honoring patients through The Reblossom Project, Allergan Aesthetics continues to support breast cancer patients through various partnerships and initiatives, including:
    Natrelle® at #CancerCulture's (R)Evolution Event during New York Fashion Week: Natrelle® was a top sponsor for (R)Evolution, a fashion show highlighting the unique stories of breast cancer previvors and thrivers.
  • The show was hosted by #CancerCulture , a nonprofit organization founded and led by breast cancer patients, in collaboration with AnaOno, a line of mastectomy bras and lingerie made for women with breast cancer.
  • Natrelle® Cares Package: A thoughtfully curated collection of items created by breast cancer survivors and other resources provided to breast cancer patients, survivors, and previvors.

Maurices Partners with Living Beyond Breast Cancer for 2nd Annual Breast Cancer Awareness Campaign

Retrieved on: 
Thursday, September 21, 2023
Survivor, Maurices, Partnership, Quality of life, Woman, LBBC, Living Beyond Breast Cancer, Patient, Breast cancer, Health, SVP, Disease, Birth control, Pharmaceutical industry

DULUTH, Minn., Sept. 21, 2023 /PRNewswire/ -- Leading women's clothing retailer, Maurices has announced its second annual partnership with Living Beyond Breast Cancer (LBBC) for their upcoming Breast Cancer Awareness Campaign. The campaign will run from September 24 through October 31, 2023, aiming to raise awareness and funds to support individuals affected by breast cancer.

Key Points: 
  • DULUTH, Minn., Sept. 21, 2023 /PRNewswire/ -- Leading women's clothing retailer, Maurices has announced its second annual partnership with Living Beyond Breast Cancer (LBBC) for their upcoming Breast Cancer Awareness Campaign.
  • During the campaign, Maurices will donate 50% of net proceeds from select products to Living Beyond Breast Cancer.
  • Join Maurices and Living Beyond Breast Cancer in the fight against breast cancer by participating in this impactful campaign from September 24 to October 31, 2023, by showcasing your limited-edition breast cancer awareness items on Instagram, TikTok or Facebook using hashtag #mauricesforgood.
  • For more information about Maurices' breast cancer awareness campaign and how you can support Living Beyond Breast Cancer, please visit www.maurices.com/giveback .

U.S. FDA Broadens Indication for Verzenio® (abemaciclib) in HR+, HER2-, Node-Positive, High Risk Early Breast Cancer

Retrieved on: 
Friday, March 3, 2023
EBC, Research, Pulmonary embolism, Oncology nursing, Risk, Living Beyond Breast Cancer, MBC, Recurrence, Woman, Monarch butterfly migration, Rated R, Neutropenia, Breast cancer, Patient, Regulation of tobacco by the U.S. Food and Drug Administration, Lancet, Food, Fetus, Neoplasm, News, LLY, Diarrhea, Cohort, Birth, Hepatotoxicity, Axis, Eli Lilly and Company, Triple-negative breast cancer, Death, FDA, Cancer, Coronary thrombosis, Sarah Cannon Research Institute, The Lancet, NYSE, ET, Thrombosis, Prognosis, ITT, Medical imaging, Vaccine, Pharmaceutical industry, Birth control, Breast, Abemaciclib

INDIANAPOLIS, March 3, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication for Verzenio® (abemaciclib), in combination with endocrine therapy (ET), for the adjuvant treatment of adult patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), node-positive, early breast cancer (EBC) at a high risk of recurrence. High risk patients eligible for Verzenio can now be identified solely based on nodal status, tumor size, and tumor grade (4+ positive nodes, or 1-3 positive nodes and at least one of the following: tumors that are ≥5 cm or Grade 3).1 This expanded adjuvant indication removes the Ki-67 score requirement for patient selection.

Key Points: 
  • The addition of Verzenio to ET reduced the risk of recurrence by 35% compared to ET alone (HR=0.653 [95% CI: 0.567-0.753]).
  • "Our goal in intensifying treatment for early breast cancer is to maintain remission and prevent the recurrence of cancer.
  • "A significant number of women and men have HR+, HER2- early breast cancer at high risk of returning.
  • We're pleased Verzenio will now be available to more people with this type of early breast cancer."

LG PRESENTS EVOLVED LUXURY EXPERIENCE WITH ITS SECOND-GENERATION LG SIGNATURE LINEUP AT CES 2023

Retrieved on: 
Thursday, December 29, 2022
Living Beyond Breast Cancer, Wine, Partnership, Wine Cellar Innovations, Electronics, Quanta Computer, Inc. v. LG Electronics, Inc., Wine cellar, OLED TV, Las Vegas Convention Center, LG Electronics, LCD, CES, OLED, Timeless, LG Corporation, LG, Thermoplastic

ENGLEWOOD CLIFFS, N.J., Dec. 28, 2022 /PRNewswire/ -- LG Electronics (LG) will unveil its second-generation LG SIGNATURE home appliance lineup at CES 2023. Offering timeless design and innovative technologies for a more convenient, stylish, and sustainable life at home, the sophisticated, new products will be on show in the LG SIGNATURE zone of LG's booth under the theme of 'Live Beyond.'

Key Points: 
  • Company's Ultra-Premium Appliances Boast Cutting-Edge Technologies, Timeless Design and Outstanding Energy Efficiency
    ENGLEWOOD CLIFFS, N.J., Dec. 28, 2022 /PRNewswire/ -- LG Electronics (LG) will unveil its second-generation LG SIGNATURE home appliance lineup at CES 2023.
  • Seven years after its launch, LG SIGNATURE continues to redefine ultra-premium – delivering elegant, highly advanced appliances and living solutions that take performance, design and usability to new heights.
  • Other LG SIGNATURE products appearing in the exhibit include an air conditioner, air purifier, OLED TV and the Wine Cellar.
  • The aesthetically refined, technologically advanced products from the LG SIGNATURE lineup will be complemented in each stylish appointed interior scene by Molteni&C's stunning furniture pieces.

LG PRESENTS DIFFERENTIATED LUXURY EXPERIENCE WITH ITS SECOND-GENERATION LG SIGNATURE LINEUP AT CES 2023

Retrieved on: 
Thursday, December 29, 2022
Living Beyond Breast Cancer, Wine, Partnership, Wine Cellar Innovations, Electronics, Wine cellar, OLED TV, Las Vegas Convention Center, LG Electronics, News, LCD, CES, OLED, Timeless, HVAC, LG, Thermoplastic

SEOUL, South Korea, Dec. 29, 2022 /PRNewswire/ -- LG Electronics (LG) will unveil its second-generation LG SIGNATURE home appliance lineup at CES 2023. Offering timeless design and innovative technologies for a more convenient, stylish, and sustainable life at home, the sophisticated, new products will be on show in the LG SIGNATURE zone of LG's booth under the theme of 'Live Beyond.'

Key Points: 
  • Company's Ultra-Premium Appliances Boast Cutting-edge Technologies, Timeless Design and Outstanding Energy Efficiency
    SEOUL, South Korea, Dec. 29, 2022 /PRNewswire/ -- LG Electronics (LG) will unveil its second-generation LG SIGNATURE home appliance lineup at CES 2023.
  • Seven years after its launch, LG SIGNATURE continues to redefine ultra-premium; delivering elegant, highly-advanced appliances and living solutions that take performance, design and usability to new heights.
  • Among other LG SIGNATURE products appearing in the exhibit are an air conditioner, air purifier, OLED TV and the Wine Cellar.
  • The LG SIGNATURE zone, comprising of living room, laundry room and kitchen, has been created in partnership with Italian designer furniture brand, Molteni&C.

How to Breast Cancer Celebrates the Patient Experience and Inspiring Medical Leadership at Annual Fundraising Gala

Retrieved on: 
Friday, October 14, 2022
Diamond, Cleveland Clinic, Manuela Vargas (flamenco dancer), Disease, Hope, Woman, Patient, Metastasis, Investor, Research, Living Beyond Breast Cancer, Program, Hematology-Oncology and Stem Cell Transplantation Research Center, Breast cancer, Daiichi Sankyo, MD, National Hispanic Heritage Month, Awareness, Optimism, BrandSafway, LBBC, Love, Medical imaging, Citrix Systems

Charity partner, Living Beyond Breast Cancer (LBBC) was the philanthropic recipient for the night.

Key Points: 
  • Charity partner, Living Beyond Breast Cancer (LBBC) was the philanthropic recipient for the night.
  • The enthusiastic crowd represented guests from across the United States who came to support How to Breast Cancer, the definitive breast cancer guide with easy-to-use tools and practices for successfully navigating a breast cancer journey, and its mission to shine a light on ways to enrich the patient experience.
  • Addressing the audience, Amelia inspired guests with her vision for change and a better way forward for breast cancer patients, especially those who are metastatic.
  • The event tonight supports LBBC and their incredible 30+ years of providing critical resources for breast cancer patients and driving funding for metastatic breast cancer research.

STANDLEE® PARTNERS WITH TOP-RATED CHARITY FOR BREAST CANCER AWARNESS

Retrieved on: 
Tuesday, October 11, 2022
Disease, Horse, Culture, VP, Woman, Hope, Survivor, Animal, Family, Living Beyond Breast Cancer, Breast cancer, Trauma, Friends, Health, Google Podcasts, Spotify, CEO, Awareness, Social media, Blog, GLOBE, Ride Beyond Vengeance, Henderson, Birth control, Apple, Norm Standlee

Kimberly, ID, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Standlee is pleased to partner with two breast cancer nonprofit organizations, Living Beyond Breast Cancer and Riding Beyond, throughout the month of October to support breast cancer awareness in a unique way.

Key Points: 
  • Kimberly, ID, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Standlee is pleased to partner with two breast cancer nonprofit organizations, Living Beyond Breast Cancer and Riding Beyond, throughout the month of October to support breast cancer awareness in a unique way.
  • Standlee visited with Ann-Marie Ramsey, a breast cancer survivor, Riding Beyond participant and volunteer, on the Beyond the Barn Podcast about the difference that horses made during her recovery of breast cancer.
  • Standlee, Living Beyond Breast Cancer, and Riding Beyond encourage everyone to support the breast cancer community in two simple ways.
  • Living Beyond Breast Cancer is a national nonprofit organization that seeks to create a world that understands there is more than one way to have breast cancer.

ALEXIS BITTAR X LIVING BEYOND BREAST CANCER

Retrieved on: 
Tuesday, October 4, 2022
Femininity, Living Beyond Breast Cancer, TWINS, Burberry, Arthritis, Portrait, History, Rheumatoid arthritis, Disgust, LBBC, Industry, Trauma, ALL, Instagram, Taboo, Ericka, Friends, Breast Cancer Awareness Month, Connie, Perfectionism, Breast cancer, BMW New Six, Beauty, Brooks Brothers, Woman, GLOBE, Awareness, Birth control, Nightclub, Alexis Bittar, Video

Some women I had never met and were introduced to me by Living Beyond Breast Cancer, LBBC and some were close friends and acquaintances.

Key Points: 
  • Some women I had never met and were introduced to me by Living Beyond Breast Cancer, LBBC and some were close friends and acquaintances.
  • Some are women Bittar knows personally and others he recently came to meet through LBBC a nationwide charity laser-focussed on supporting women and families affected by breast cancer.
  • The campaign marks October Breast Cancer Awareness Month, Alexis Bittar is working with Living Beyond Breast Cancer, LBBC.
  • For 48 hours (October 19th & 20th) Alexis will be donating 50% of ALL sales across all six of his freestanding boutiques and his website directly to LBBC - There will be an event in Alexis Bittar Stores in NYC and San Francisco on October 19th to celebrate the collaboration and to generate sales for Living Beyond Breast Cancer Charity.

Maurices Partners with Living Beyond Breast Cancer to Support Women's Health During Breast Cancer Awareness Month

Retrieved on: 
Thursday, September 29, 2022
Living Beyond Breast Cancer, Heart, Breast cancer, Knitting, CEO, Awareness, Multimedia, Woman, Partnership, Breast Cancer Awareness Month, Disease, Sale, Love, Pharmaceutical industry, Birth control, Dietary supplement, Maurices

Available for $19.90 online and in stores, $10 from the sale of each tee will be donated to Living Beyond Breast Cancer.

Key Points: 
  • Available for $19.90 online and in stores, $10 from the sale of each tee will be donated to Living Beyond Breast Cancer.
  • In addition, Maurices will be donating $20,000 to Living Beyond Breast Cancer.
  • Customers can also donate directly to Living Beyond Breast Cancer during checkout at Maurices' nearly 900 stores across the U.S.
    "Living Beyond Breast Cancer is thrilled to partner with Maurices, a brand that serves women every day and understands that information and support are critical when diagnosed with breast cancer," stated Jean Sachs, CEO of Living Beyond Breast Cancer.
  • Living Beyond Breast Cancer is a national nonprofit organization that seeks to create a world that understands there is more than one way to have breast cancer.